Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer (Q43621492)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer |
scientific article |
Statements
1 reference
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer (English)
1 reference
Namer M
1 reference
Soler-Michel P
1 reference
Turpin F
1 reference
Chinet-Charrot P
1 reference
de Gislain C
1 reference
Pouillart P
1 reference
Delozier T
1 reference
Luporsi E
1 reference
Etienne PL
1 reference
Schraub S
1 reference
Eymard JC
1 reference
Serin D
1 reference
Ganem G
1 reference
Calais G
1 reference
Maillart P
1 reference
Colin P
1 reference
Trillet-Lenoir V
1 reference
Prevost G
1 reference
Tigaud D
1 reference
Clavère P
1 reference
Marti P
1 reference
Romieu G
1 reference
Wendling JL
1 reference
1 June 2001
1 reference
1 reference
37
1 reference
9
1 reference
1132-1140
1 reference
Identifiers
1 reference
1 reference